Parameters Findings Findings Remarks
Anti Neutrophil Cytoplasmic Antibodies (IFA) Anti Neutrophil Cytoplasmic Antibodies (IFA) Anti Neutrophil Cytoplasmic Antibodies (IFA) Anti Neutrophil Cytoplasmic Antibodies (IFA)
c-ANCA c-ANCA 1.37 U/ml Negative
p-ANCA p-ANCA - Negative
Fluorescent In situ hybridization (FISH)- Eosinophilic Leukemia Panel Fluorescent In situ hybridization (FISH)- Eosinophilic Leukemia Panel Fluorescent In situ hybridization (FISH)- Eosinophilic Leukemia Panel Fluorescent In situ hybridization (FISH)- Eosinophilic Leukemia Panel
PDGFRA rearrangement (4q12) PDGFRA rearrangement (4q12) 0 Negative
PDGFRB rearrangement (5q33) PDGFRB rearrangement (5q33) 0 Negative
FGFR1 rearrangement (8p11.22-11.23) FGFR1 rearrangement (8p11.22-11.23) 0 Negative
CBFB rearrangement (Inv 16) CBFB rearrangement (Inv 16) 0 Negative
Bone marrow examination Bone marrow examination Bone marrow examination Bone marrow examination
Cellularity Cellularity Hypercellular
Erythroid series Erythroid series Present with normoblastic maturation
Myeloid series Myeloid series Increased with progressive maturation up to neutrophils. Markedly increased eosinophils and precursors were noted, which show dysplasia in the form of abnormal segmentation and irregular distribution of granules. Myeloid hyperplasia